Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub

Share

July 2020; 7 (4) ArticleOpen Access

Risk of MS relapse after yellow fever vaccination

A self-controlled case series

Angela Huttner, View ORCID ProfileGilles Eperon, Agustina M. Lascano, Serge Roth, Jean-Marc Schwob, Claire-Anne Siegrist, Patrice H. Lalive
First published May 1, 2020, DOI: https://doi.org/10.1212/NXI.0000000000000726
Angela Huttner
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Eperon
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gilles Eperon
Agustina M. Lascano
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge Roth
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Marc Schwob
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire-Anne Siegrist
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrice H. Lalive
From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Risk of MS relapse after yellow fever vaccination
A self-controlled case series
Angela Huttner, Gilles Eperon, Agustina M. Lascano, Serge Roth, Jean-Marc Schwob, Claire-Anne Siegrist, Patrice H. Lalive
Neurol Neuroimmunol Neuroinflamm Jul 2020, 7 (4) e726; DOI: 10.1212/NXI.0000000000000726

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
658

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 7 no. 4 e726
DOI: 
https://doi.org/10.1212/NXI.0000000000000726
PubMed: 
32358223

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received October 22, 2019
  • Accepted in final form March 20, 2020
  • First Published May 1, 2020.

Copyright & Usage: 
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Angela Huttner, MD,
    2. Gilles Eperon, MD,
    3. Agustina M. Lascano, MD, PhD,
    4. Serge Roth, MD,
    5. Jean-Marc Schwob, MD,
    6. Claire-Anne Siegrist, MD and
    7. Patrice H. Lalive, MD
  1. Angela Huttner, MD,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. Swiss National Science Foundation, 74th National Research Program “Smarter Health Care” (no. 407440_167359), PI (unrelated trial on antibiotic duration in gram-negative bacteremia), 2017-2020

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Gilles Eperon, MD,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. Academic fund (Hopitaux Universitaires de Genève et Université de Genève, Fonds MIMOSA) for another study (on-going) on vaccinal immunogenicity for MS patients with NSB/FGD

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Agustina M. Lascano, MD, PhD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Serge Roth, MD,
  8. Scientific Advisory Boards:
    1. Fees for Advisory Boards from Novartis, Biogen, Merk,Teva, Sanofi-Genzyme, Roche

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. Travel grants from Novartis, Biogen, Merk, Teva, Roche

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Jean-Marc Schwob, MD,
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Claire-Anne Siegrist, MD and
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  13. Patrice H. Lalive, MD
  14. Scientific Advisory Boards:
    1. (1) Biogen-Idec (2) Novartis (3) Merck (4) Roche

    Gifts:
    1. NONE

    Funding for travel or speaker honoraria:
    1. (1) Biogen-Idec (2)Teva (3) Merck (4) Roche

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From the Center for Vaccinology (A.H., C.-A.S.), University of Geneva; Division of Infectious Diseases (A.H.), Geneva University Hospitals; Division of Tropical and Humanitarian Medicine (G.E., J.-M.S.), Geneva University Hospitals; Department of Neurosciences (A.M.L., S.R., P.H.L.), Division of Neurology, Unit of Neuroimmunology and Neuromuscular Diseases, Geneva University Hospitals; Department of Pathology and Immunology (C.-A.S., P.H.L.), Faculty of Medicine, University of Geneva; and Division of Laboratory Medicine (P.H.L.), Department of Diagnostic, Geneva University Hospitals, Switzerland.
  1. Correspondence
    Dr. Lalive patrice.lalive{at}hcuge.ch
View Full Text

Article usage

Article usage: May 2020 to May 2022

AbstractFullPdfSource
May 202028516148Highwire
Jun 202028625Highwire
Jul 202017825449Highwire
Aug 2020413415Highwire
Sep 2020810816Highwire
Oct 202029029Highwire
Nov 202029634Highwire
Dec 2020410518Highwire
Jan 2021510024Highwire
Feb 202167515Highwire
Mar 2021107014Highwire
Apr 20212799Highwire
May 202128617Highwire
Jun 202197618Highwire
Jul 202146015Highwire
Aug 202137021Highwire
Sep 2021617023Highwire
Oct 20211311228Highwire
Nov 202127127Highwire
Dec 202147017Highwire
Jan 202277416Highwire
Feb 202246014Highwire
Mar 202238220Highwire
Apr 202266627Highwire
May 202267719Highwire

Cited By...

  • 13 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study funding
    • Disclosure
    • Acknowledgment
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures

Related Articles

  • No related articles found.

Topics Discussed

  • Multiple sclerosis

Alert Me

  • Alert me when eletters are published
Advertisement
Neurology - Neuroimmunology Neuroinflammation: 9 (5)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise